Front Desk: 469-391-0070
Chlorambucil Medication: Uses, Dosage, and Cancer Treatment
Summary of Key Points
Chlorambucil is a prescription medication primarily used to treat certain types of cancer, including leukemia and lymphoma. It works by slowing or stopping the growth of cancer cells. Chlorambucil is typically taken orally in tablet form, with the dosage varying depending on the specific condition being treated. Like all medications, it may cause side effects, so it’s important to follow your doctor’s instructions closely. If you have any questions about Chlorambucil, consult one of our telemedicine providers for guidance.
Names of Medication
US Brand Name: Leukeran
Generic Name: Chlorambucil
The generic name refers to the active ingredient, while the brand name is assigned by the manufacturer. In this article, the generic name Chlorambucil will be used in parentheses where applicable.
Pharmacologic Category
Chlorambucil belongs to the class of drugs known as Alkylating Agents. These medications treat cancer by damaging the DNA of cancer cells, preventing them from multiplying. This mechanism makes Chlorambucil an effective chemotherapy option for various cancers.
Chlorambucil Dosage
Chlorambucil is used to treat several types of cancer and autoimmune diseases. The dosing schedule can vary depending on the specific condition being treated. Always consult your doctor before making any changes to your Chlorambucil dosage.
Chronic Lymphocytic Leukemia (CLL)
Initial dose: 0.1 to 0.2 mg/kg orally once daily for 3 to 6 weeks.
Maintenance dose: Adjust based on response and blood counts.
Non-Hodgkin Lymphoma
Initial dose: 0.1 to 0.2 mg/kg orally once daily for 3 to 6 weeks.
Maintenance dose: Adjust based on response and blood counts.
Hodgkin Lymphoma
Initial dose: 0.1 to 0.2 mg/kg orally once daily for 3 to 6 weeks.
Maintenance dose: Adjust based on response and blood counts.
Waldenström Macroglobulinemia
Initial dose: 6 to 12 mg/day orally for 3 to 6 weeks.
Maintenance dose: Adjust based on response and blood counts.
Multiple Myeloma
Initial dose: 0.15 mg/kg orally once daily for 7 days.
Maintenance dose: Adjust based on response and blood counts.
Autoimmune Diseases
Initial dose: 0.1 to 0.2 mg/kg orally once daily for 3 to 6 weeks.
Maintenance dose: Adjust based on response and blood counts.
Lymphocytic Leukemia
Initial dose: 0.1 to 0.2 mg/kg orally once daily for 3 to 6 weeks.
Maintenance dose: Adjust based on response and blood counts.
Mycosis Fungoides
Initial dose: 0.1 to 0.2 mg/kg orally once daily for 3 to 6 weeks.
Maintenance dose: Adjust based on response and blood counts.
Hairy Cell Leukemia
Initial dose: 0.1 to 0.2 mg/kg orally once daily for 3 to 6 weeks.
Maintenance dose: Adjust based on response and blood counts.
Chronic Myeloid Leukemia (CML)
Initial dose: 0.1 to 0.2 mg/kg orally once daily for 3 to 6 weeks.
Maintenance dose: Adjust based on response and blood counts.
Dosage Forms and Strengths
Chlorambucil is available in the form of Oral Tablets: 2 mg.
Administration Instructions for Chlorambucil
Take Chlorambucil exactly as prescribed by your doctor. It is usually taken once daily, with or without food. Swallow the tablet whole with water; do not crush or chew it. If you miss a dose, take it as soon as you remember, unless it’s almost time for your next dose. In that case, skip the missed dose and continue with your regular schedule. Do not take two doses at once to make up for a missed dose.
Contraindications for Chlorambucil
Contraindications are specific situations where a drug should not be used due to potential harm. Chlorambucil has several contraindications, meaning it may be unsafe for certain individuals. Below are the main contraindications for Chlorambucil and the reasons why it is not recommended in these cases:
Allergy to Chlorambucil: If you are allergic to Chlorambucil or any of its components, taking this medication could trigger a severe allergic reaction, which may include symptoms like rash, difficulty breathing, or swelling.
Severe Bone Marrow Suppression: Chlorambucil can further suppress bone marrow function, leading to dangerously low blood cell levels. This is particularly risky for patients who already have low blood cell counts.
Active Infections: Chlorambucil weakens the immune system, making it harder for your body to fight infections. If you have an active infection, taking Chlorambucil could worsen your condition.
Pregnancy: Chlorambucil can harm an unborn baby, so it is not recommended during pregnancy (see more details in the pregnancy section below).
Chlorambucil Drug Interactions
Chlorambucil can interact with other medications, which may increase the risk of side effects or reduce the effectiveness of either drug. Below are some medications that may interact with Chlorambucil:
Allopurinol (Zyloprim): Used to treat gout, this medication may increase the risk of bone marrow suppression when taken with Chlorambucil.
Phenytoin (Dilantin): An anti-seizure medication that can reduce the effectiveness of Chlorambucil.
Live Vaccines: Vaccines such as the MMR (measles, mumps, rubella) or varicella (chickenpox) vaccines should be avoided while taking Chlorambucil, as your immune system may not respond appropriately to live vaccines.
Immunosuppressants: Medications such as cyclosporine (Neoral) or tacrolimus (Prograf) may increase the risk of infections when combined with Chlorambucil.
Chlorambucil in Pregnancy
Is it safe to take Chlorambucil when pregnant?
Chlorambucil is generally not considered safe during pregnancy. It is classified as a Category D medication by the FDA, meaning it poses a significant risk to the developing fetus, potentially leading to birth defects or other serious complications. If you are pregnant or planning to become pregnant, it is crucial to consult your healthcare provider to explore safer alternatives. If you are currently taking Chlorambucil and discover you are pregnant, contact your healthcare provider immediately to discuss your options. Our telemedicine providers are available to support you through this process and help you make informed decisions.
Chlorambucil while Breastfeeding
Is it safe to take Chlorambucil while breastfeeding?
Chlorambucil is not recommended for use while breastfeeding, as it can pass into breast milk and potentially harm your baby. If you are breastfeeding or planning to breastfeed, it’s important to speak with your healthcare provider about alternative treatments. You may need to consider either discontinuing breastfeeding or switching to a different medication. Our telemedicine providers are here to help you navigate these choices and find the best solution for both you and your child.
Estimated Cost of Chlorambucil Medication
The cost of a 30-day supply of Chlorambucil without insurance can vary depending on the pharmacy and your location. However, with a GoodRx coupon, the estimated price for a 30-day supply of Chlorambucil (2 mg tablets) typically ranges from $400 to $600. Prices may fluctuate, so it’s a good idea to check with your pharmacy or use a coupon service like GoodRx to find the most affordable option.
Possible Alternatives to Chlorambucil
Depending on your specific condition, there may be alternative medications or lifestyle adjustments that can help manage your disease. Always consult your healthcare provider before making any changes to your treatment plan. Our telemedicine providers are available to guide you through these options and help you make the best decision for your health.
Chronic Lymphocytic Leukemia
Alternatives to Chlorambucil for chronic lymphocytic leukemia (CLL) include targeted therapies such as ibrutinib (Imbruvica) or venetoclax (Venclexta). In addition to medication, maintaining a healthy diet and engaging in regular physical activity can support your overall well-being.
Non-Hodgkin Lymphoma
For non-Hodgkin lymphoma, alternative treatments may include rituximab (Rituxan) or bendamustine (Treanda). It’s important to discuss with your healthcare provider whether these options are appropriate for your specific case.
Hodgkin Lymphoma
ABVD chemotherapy, which includes doxorubicin, bleomycin, vinblastine, and dacarbazine, is a common alternative treatment for Hodgkin lymphoma. Additionally, managing stress and maintaining a balanced diet can contribute to an improved quality of life during treatment.
Waldenström Macroglobulinemia
Ibrutinib (Imbruvica) is a targeted therapy that may be used as an alternative for Waldenström macroglobulinemia. Regular monitoring and adopting a healthy lifestyle can also play a role in managing the condition effectively.
Multiple Myeloma
For multiple myeloma, alternative treatments may include lenalidomide (Revlimid) or bortezomib (Velcade). Staying physically active and following a nutritious diet can further enhance your overall health and well-being.
Autoimmune Diseases
In the case of autoimmune diseases, methotrexate or azathioprine (Imuran) may be considered as alternatives to Chlorambucil. Incorporating lifestyle changes such as stress management, regular exercise, and a healthy diet can also support your treatment and improve your quality of life.
Lymphocytic Leukemia
Targeted therapies like ibrutinib (Imbruvica) may be viable alternatives for lymphocytic leukemia. Be sure to discuss with your healthcare provider whether these options are suitable for your specific condition.
Mycosis Fungoides
For mycosis fungoides, alternatives may include phototherapy or topical treatments. Additionally, maintaining proper skin hydration and using sun protection can help manage symptoms and improve skin health.
Hairy Cell Leukemia
Cladribine (Leustatin) is a commonly used alternative treatment for hairy cell leukemia. Regular medical check-ups and adopting a healthy lifestyle can help manage the disease and improve your overall health.
Chronic Myeloid Leukemia
Imatinib (Gleevec) is a targeted therapy that may be used as an alternative for chronic myeloid leukemia. Incorporating regular exercise and a balanced diet into your routine can support your overall health and treatment outcomes.
Recent Updates on Chlorambucil Research
Recent research on Chlorambucil has focused on improving its effectiveness while minimizing side effects. Studies are exploring combination therapies that pair Chlorambucil with newer targeted treatments, such as ibrutinib (Imbruvica) and obinutuzumab (Gazyva), particularly for chronic lymphocytic leukemia (CLL). These combinations may offer improved outcomes by enhancing the drug’s ability to target cancer cells while reducing harm to healthy cells.
Additionally, ongoing research is investigating the use of Chlorambucil in lower doses or in combination with immunotherapy to reduce the risk of long-term side effects, such as secondary cancers or severe bone marrow suppression. If you are interested in learning more about these emerging treatment options, our telemedicine providers can help you understand how they may apply to your specific situation.
